康妇炎胶囊的妇科临床应用及作用机制探讨
Clinical Application and Mechanisms of Action of Kangfuyan Capsules in Gynecology
DOI: 10.12677/acm.2025.151267, PDF,   
作者: 赵子佳*, 马伊杰:云南中医药大学第一临床医学院,云南 昆明;陈冬琼#:云南中医药大学第一附属医院妇科,云南 昆明
关键词: 康妇炎胶囊妇科炎症临床应用作用机制抗炎Kangfuyan Capsules Gynecological Inflammation Clinical Application Mechanism of Action Anti-Inflammatory
摘要: 康妇炎胶囊是在经典中药组方薏苡附子败酱散、当归芍药散及二妙散基础上加减而成,主要由香附、川芎、赤芍、延胡索、当归、白花蛇舌草、蒲公英、泽泻、薏苡仁、败酱草和苍术等中药组成,具有清热解毒、化湿止带、活血通络止痛的功效。本文综述了康妇炎胶囊在治疗妇科炎症性疾病中的临床应用及其作用机制。通过抗炎镇痛、抗菌、调节免疫功能、改善血液流变学、抑制血管生成和减少盆腔结缔组织生成等多重药理作用,康妇炎胶囊在慢性盆腔炎、阴道炎、宫颈病变、子宫内膜炎及输卵管通而不畅性不孕等疾病的治疗中表现出显著疗效。临床研究表明,康妇炎胶囊联合常规治疗方法能够有效降低炎症因子水平,改善免疫指标,减少症状持续时间及疾病复发率,且具有较低的副作用发生率。因此,康妇炎胶囊在妇科炎症性疾病的综合治疗中具有重要的临床价值和广阔的应用前景。
Abstract: Kangfuyan Capsules are developed based on the classical Chinese medicine formulas of Yiyi Fuzi Baijiang San, Danggui Shaoyao San, and Ermiao San, with modifications. The primary ingredients include Xiangfu, Chuanxiong, Chishaoyao, Yanhusuo, Danggui, Baihuasheshecao, Pugongying, Zexie, Yiyiren, Baijiangcao, and Cangzhu. This formulation possesses the functions of clearing heat and detoxifying, dispelling dampness and stopping leukorrhea, promoting blood circulation, and relieving pain. This review summarizes the clinical applications and mechanisms of action of Kangfuyan Capsules in treating gynecological inflammatory diseases. Through multiple pharmacological actions, such as anti-inflammatory and analgesic effects, antibacterial activity, immune modulation, improvement of blood rheology, inhibition of angiogenesis, and reduction of pelvic connective tissue generation, Kangfuyan Capsules have shown significant efficacy in the treatment of chronic pelvic inflammatory disease, vaginitis, cervical lesions, endometritis, and tubal infertility caused by obstructed fallopian tubes. Clinical studies indicate that when combined with conventional treatments, Kangfuyan Capsules can effectively lower the levels of inflammatory factors, improve immune indicators, reduce the duration of symptoms, and decrease the recurrence rate of the diseases, with a relatively low incidence of side effects. Therefore, Kangfuyan Capsules hold significant clinical value and promising application prospects in the comprehensive treatment of gynecological inflammatory diseases.
文章引用:赵子佳, 马伊杰, 陈冬琼. 康妇炎胶囊的妇科临床应用及作用机制探讨[J]. 临床医学进展, 2025, 15(1): 2007-2017. https://doi.org/10.12677/acm.2025.151267

参考文献

[1] 郝菁菁. 康妇炎胶囊治疗慢性盆腔炎效果分析[J]. 中国城乡企业卫生, 2020, 35(8): 181-182.
[2] 《中成药治疗优势病种临床应用指南》标准化项目组. 中成药治疗盆腔炎性疾病后遗症临床应用指南(2020年) [J]. 中国中西医结合杂志, 2021, 41(3): 286-299.
[3] 王丽颖, 刘孟宇, 宇文亚, 等. 《中医妇科常见病诊疗指南》临床应用评价研究[J]. 中国中药杂志, 2017, 42(17): 3262-3266.
[4] 徐长丽, 谷庆花, 赵光瑞, 等. 蒲公英和金银花对海洋病原菌的抑菌作用[J]. 江苏海洋大学学报(自然科学版), 2022, 31(3): 31-35.
[5] Chen, L., Jan, Y., Tsai, P., Norimoto, H., Michihara, S., Murayama, C., et al. (2016) Anti-Inflammatory and Antinociceptive Constituents of Atractylodes japonica Koidzumi. Journal of Agricultural and Food Chemistry, 64, 2254-2262. [Google Scholar] [CrossRef] [PubMed]
[6] Li, L., He, Y., Wang, N., Li, Y., Du, Y., He, N., et al. (2023) Atractylone in the Atractylodes Macrocephala Rhizoma Essential Oil and Its Anti-Inflammatory Activity. Molecules, 28, Article No. 7340. [Google Scholar] [CrossRef] [PubMed]
[7] Resch, M., Steigel, A., Chen, Z. and Bauer, R. (1998) 5-Lipoxygenase and Cyclooxygenase-1 Inhibitory Active Compounds from Atractylodes lancea. Journal of Natural Products, 61, 347-350. [Google Scholar] [CrossRef] [PubMed]
[8] 赵涛, 赵步长, 豆婧婧. 康妇炎胶囊治疗盆腔炎性疾病研究进展[J]. 中国妇幼保健, 2014, 29(34): 5730-5732.
[9] 樊亚东, 张晓雨, 王惠津. 康妇炎胶囊治疗盆腔炎性疾病的网络药理学机制分析[J]. 天津药学, 2021, 33(3): 31-35.
[10] Antonelli, M. and Kushner, I. (2017) It’s Time to Redefine Inflammation. The FASEB Journal, 31, 1787-1791. [Google Scholar] [CrossRef] [PubMed]
[11] He, M.M., Smith, A.S., Oslob, J.D., Flanagan, W.M., Braisted, A.C., Whitty, A., et al. (2005) Small-Molecule Inhibition of TNF-α. Science, 310, 1022-1025. [Google Scholar] [CrossRef] [PubMed]
[12] Sun, R., Gao, D.S., Shoush, J. and Lu, B. (2022) The IL-1 Family in Tumorigenesis and Antitumor Immunity. Seminars in Cancer Biology, 86, 280-295. [Google Scholar] [CrossRef] [PubMed]
[13] Applequist, S.E., Wallin, R.P. and Ljunggren, H.G. (2002) Variable Expression of Toll-Like Receptor in Murine Innate and Adaptive Immune Cell Lines. International Immunology, 14, 1065-1074. [Google Scholar] [CrossRef] [PubMed]
[14] 王群, 周红光. 中药调节TLRS/NF-κB信号通路研究进展[J]. 辽宁中医杂志, 2011, 38(5): 1021-1023.
[15] 费红梅. 慢性盆腔炎患者血清TNF-α、IL-1β、IL-4及T淋巴细胞亚群分布变化[J]. 山东医药, 2015, 55(38): 60-61.
[16] 熊英, 马宏莲. 血清IL-6, IL-8与宫颈sIgA联合检测对女性慢性盆腔炎的诊断价值研究[J]. 转化医学杂志, 2019, 8(4): 218-221.
[17] 徐美秀. 血清单核细胞趋化蛋白-1、C反应蛋白、白细胞介素-2在妇科盆腔炎感染患者中的诊断价值[J]. 医疗装备, 2019, 32(15): 48-49.
[18] 陈军, 周盈盈, 陈黎黎, 等. miR-106b对脂多糖诱导活化的人单核巨噬细胞分泌TNF-α的影响及机制研究[J]. 浙江医学, 2018, 40(20): 2207-2210.
[19] Tanaka, T., Kanda, T., McManus, B.M., Kanai, H., Akiyama, H., Sekiguchi, K., et al. (2001) Overexpression of Interleukin-6 Aggravates Viral Myocarditis: Impaired Increase in Tumor Necrosis Factor-α. Journal of Molecular and Cellular Cardiology, 33, 1627-1635. [Google Scholar] [CrossRef] [PubMed]
[20] Sproston, N.R. and Ashworth, J.J. (2018) Role of C-Reactive Protein at Sites of Inflammation and Infection. Frontiers in Immunology, 9, Article No. 754. [Google Scholar] [CrossRef] [PubMed]
[21] 王月平, 尹飞飞, 赵国厚, 等. 血清CRP、IL-6、PCT在支气管扩张症合并肺部感染中的表达水平及意义[J]. 中华医院感染学杂志, 2020, 30(9): 1350-1354.
[22] 李艳蓉, 王洪伟, 符琴, 等. 基于TLRs-NF-κB信号通路探讨抗生素药物联合康妇炎胶囊治疗慢性子宫内膜炎疗效及机制[J]. 中国计划生育学杂志, 2023, 31(2): 311-315.
[23] 樊慧敏. 康妇炎胶囊联合甲硝唑治疗盆腔炎疾病的效果分析[J]. 实用妇科内分泌电子杂志, 2024, 11(17): 58-60.
[24] 李小燕, 厉佳, 赵梦梦. 康妇炎胶囊联合抗生素治疗盆腔炎对临床症状及炎症指标的影响[J]. 中国妇幼保健, 2024, 39(9): 1581-1584.
[25] 霍红, 吕占秋. 康妇炎胶囊结合抗生素在门诊慢性盆腔炎患者治疗中的价值[J]. 实用妇科内分泌电子杂志, 2023, 10(30): 98-100.
[26] 司清晨, 叶燕婷, 古贺欢. 桂枝茯苓丸联合微波治疗仪对气滞血瘀型慢性盆腔炎患者临床疗效、症状改善及炎症因子水平的影响[J]. 临床研究, 2023, 31(7): 78-81.
[27] Kitchen, S.G., Whitmire, J.K., Jones, N.R., Galic, Z., Kitchen, C.M.R., Ahmed, R., et al. (2005) The CD4 Molecule on Cd8+ T Lymphocytes Directly Enhances the Immune Response to Viral and Cellular Antigens. Proceedings of the National Academy of Sciences, 102, 3794-3799. [Google Scholar] [CrossRef] [PubMed]
[28] Nascimbeni, M., Shin, E., Chiriboga, L., Kleiner, D.E. and Rehermann, B. (2004) Peripheral CD4+CD8+ T Cells Are Differentiated Effector Memory Cells with Antiviral Functions. Blood, 104, 478-486. [Google Scholar] [CrossRef] [PubMed]
[29] 子建文, 赵黎明. 急性盆腔炎患者CRP、IL-2及T细胞亚群测定的临床意义[J]. 西南国防医药, 2009, 19(2): 226-227.
[30] 刘春玲. 女性盆腔炎性疾病患者T淋巴细胞亚群变化分析[J]. 中国实验诊断学, 2011, 15(5): 882-884.
[31] 何延浩, 李冀红, 肖云芳, 等. 康妇炎胶囊治疗大鼠盆腔炎性疾病后遗症的实验研究[J]. 中国临床药理学杂志, 2017, 33(12): 1139-1142.
[32] 金秀萍, 魏顺英. 康妇炎胶囊灌肠联合人胎盘组织液肌肉注射治疗肾虚湿热型慢性盆腔炎疗效观察[J]. 现代中西医结合杂志, 2017, 26(35): 3939-3941.
[33] 王爱红, 胡春芹. 康妇炎胶囊联合阿奇霉素治疗支原体感染盆腔炎临床疗效观察[J]. 临床合理用药杂志, 2018, 11(34): 87-88.
[34] 丁微薇. 桂枝茯苓丸联合妇科千金胶囊治疗卵巢囊肿临床观察[J]. 中国中医药现代远程教育, 2024, 22(10): 59-61.
[35] 谷风, 严英, 陶红星. 利湿化瘀中药对慢性盆腔炎血液流变学及血清C-反应蛋白的影响[J]. 中华中医药杂志, 2011, 26(5): 1102-1105.
[36] 李学娟, 李喜香, 古秋莉, 等. 附炎栓对宫颈炎模型大鼠血液流变学的影响[J]. 西部中医药, 2017, 30(9): 46-48.
[37] 潘刘英. 妇炎汤联合抗生素与单用抗生素对慢性盆腔炎患者疗效、抗炎及血液流变学对照研究[J]. 中华中医药学刊, 2011, 29(7): 1703-1704.
[38] 顾海娜, 谢琼艳, 李书艳, 等. 康妇炎胶囊对支原体属感染慢性盆腔炎血清炎症因子及盆腔血流动力学的影响[J]. 中华中医药学刊, 2023, 41(2): 201-204.
[39] 刘柏岑, 王清香. 左氧氟沙星联合康妇炎胶囊对急性盆腔炎患者炎性因子的影响观察[J]. 现代诊断与治疗, 2022, 33(9): 1286-1288.
[40] Takahashi, H. and Shibuya, M. (2005) The Vascular Endothelial Growth Factor (VEGF)/VEGF Receptor System and Its Role under Physiological and Pathological Conditions. Clinical Science, 109, 227-241. [Google Scholar] [CrossRef] [PubMed]
[41] Ke, L.D., Shi, Y.X. and Yung, W.K. (2002) VEGF(121), VEGF(165) Overexpression Enhances Tumorigenicity in U251 MG But Not in NG-1 Glioma Cells. Cancer Research, 62, 1854-1861.
[42] 蔡竞, 贺丰杰, 朱虹丽, 等. 康妇炎胶囊对兔盆腔炎性疾病后遗症模型粘连相关指标影响的实验研究[J]. 陕西中医, 2015, 36(11): 1552-1554+1560.
[43] Dean, R.A., Butler, G.S., Hamma-Kourbali, Y., Delbé, J., Brigstock, D.R., Courty, J., et al. (2007) Identification of Candidate Angiogenic Inhibitors Processed by Matrix Metalloproteinase 2 (MMP-2) in Cell-Based Proteomic Screens: Disruption of Vascular Endothelial Growth Factor (VEGF)/Heparin Affin Regulatory Peptide (Pleiotrophin) and VEGF/Connective Tissue Growth Factor Angiogenic Inhibitory Complexes by MMP-2 Proteolysis. Molecular and Cellular Biology, 27, 8454-8465. [Google Scholar] [CrossRef] [PubMed]
[44] Hardy, E., Hardy-Sosa, A. and Fernandez-Patron, C. (2018) MMP-2: Is Too Low as Bad as Too High in the Cardiovascular System? American Journal of Physiology-Heart and Circulatory Physiology, 315, H1332-H1340. [Google Scholar] [CrossRef] [PubMed]
[45] 徐曦, 李艳, 袁远霞, 等. 康妇炎胶囊联合头孢噻肟钠治疗子宫内膜炎的临床研究[J]. 现代药物与临床, 2020, 35(4): 688-691.
[46] Deng, Z., Fan, T., Xiao, C., Tian, H., Zheng, Y., Li, C., et al. (2024) TGF-β Signaling in Health, Disease and Therapeutics. Signal Transduction and Targeted Therapy, 9, Article No. 61. [Google Scholar] [CrossRef] [PubMed]
[47] Zhang, C., Zhu, X., Hua, Y., Zhao, Q., Wang, K., Zhen, L., et al. (2019) YY1 Mediates TGF-β1-Induced EMT and Pro-Fibrogenesis in Alveolar Epithelial Cells. Respiratory Research, 20, Article No. 249. [Google Scholar] [CrossRef] [PubMed]
[48] 蔡竞, 贺丰杰, 朱虹丽, 等. 康妇炎胶囊对兔盆腔炎性疾病后遗症炎症因子影响的实验研究[J]. 中国妇产科临床杂志, 2015, 16(4): 347-350.
[49] 王宏明. 康妇炎胶囊联合常规西药治疗慢性盆腔炎患者的效果[J]. 中国民康医学, 2024, 36(4): 120-122.
[50] 钟丽苹. 雷火灸联合康妇炎胶囊加头孢呋辛钠治疗慢性盆腔炎临床观察[J]. 光明中医, 2023, 38(18): 3615-3618.
[51] 《中成药治疗优势病种临床应用指南》标准化项目组. 中成药治疗阴道炎临床应用指南(2022年) [J]. 中国中西医结合杂志, 2023, 43(8): 901-910.
[52] 崔欣. 康妇炎胶囊联合苦参碱栓治疗阴道炎的临床疗效[J]. 内蒙古中医药, 2023, 42(7): 82-83.
[53] 吴丽, 胡艳红, 刘暻. 康妇炎胶囊联合红核妇洁洗液治疗霉菌性阴道炎临床观察[J]. 实用中医药杂志, 2024, 40(1): 8-10.
[54] 张燕. 康妇炎胶囊联合奥硝唑治疗耐药性滴虫性阴道炎的疗效观察[J]. 山东医学高等专科学校学报, 2023, 45(4): 279-281.
[55] 李晓秋. 康妇炎胶囊对老年念珠菌性阴道炎的临床效果观察[J]. 实用妇科内分泌电子杂志, 2021, 8(14): 32-34.
[56] 何国梅. LEEP刀联合重组人干扰素α-2b栓治疗HPV感染重型宫颈病变的临床疗效[J]. 中国生育健康杂志, 2017, 28(2): 164-167.
[57] 许彩芹, 李艳华, 李颖敏, 等. 保妇康栓和干扰素联合中药治疗低度宫颈上皮内瘤变合并高危型HPV感染的疗效观察[J]. 中国妇幼保健, 2017, 32(20): 4932-4934.
[58] 刘丽琳. 中药康妇炎胶囊联合LEEP刀治疗宫颈病变的疗效观察[J]. 中外女性健康研究, 2019(19): 48-49.
[59] 祝妮娜, 何思敏. 康妇炎胶囊联合保妇康栓治疗宫颈柱状上皮异位的效果[J]. 临床医学研究与实践, 2023, 8(5): 111-114.
[60] 陈丽娜, 王秀霞. 慢性子宫内膜炎诊断方法的研究进展[J]. 中国实用妇科与产科杂志, 2021, 37(2): 245-247.
[61] 丘甜美, 何援利, 蔡慧华. 子宫内膜炎性反应与宫腔粘连的相关性[J]. 现代妇产科进展, 2019, 28(4): 317-318+320.
[62] 张小燕, 郭和坚, 范希景, 等. 左氧氟沙星联合甲羟孕酮对子宫内膜炎患者炎症细胞因子与免疫功能的影响[J]. 中国妇幼保健, 2023, 38(11): 1979-1982.
[63] 卢路艳, 程芳, 马希佳. 黄藤素胶囊联合左氧氟沙星治疗子宫内膜炎的临床研究[J]. 现代药物与临床, 2021, 36(3): 534-537.
[64] 班海梅. 康妇炎胶囊联合头孢噻肟钠治疗子宫内膜炎的疗效观察[J]. 中国医药指南, 2023, 21(30): 143-145.
[65] 刘霞, 刘颖, 黄婷. 康妇炎和妇科千金片联合治疗子宫内膜炎的疗效分析[J]. 中外医疗, 2023, 42(29): 84-87.
[66] 黄荷凤, 王波, 朱依敏. 不孕症发生现状及趋势分析[J]. 中国实用妇科与产科杂志, 2013, 29(9): 688-690.
[67] 和晓利, 张宁, 李雅丽, 等. 宫腹腔镜联合治疗输卵管性不孕的临床价值[J]. 医药论坛杂志, 2020, 41(4): 1-4.
[68] Tsevat, D.G., Wiesenfeld, H.C., Parks, C. and Peipert, J.F. (2017) Sexually Transmitted Diseases and Infertility. American Journal of Obstetrics and Gynecology, 216, 1-9. [Google Scholar] [CrossRef] [PubMed]
[69] 陈丹, 林妙珊. 中西医结合治疗输卵管炎性不孕症的研究进展[J]. 光明中医, 2019, 34(19): 3057-3059.
[70] 李盼盼, 高慧, 刘玉兰, 等. 输卵管阻塞性不孕症的中西医研究进展[J]. 现代中西医结合杂志, 2021, 30(23): 2605-2610.
[71] 罗芳, 廉阳秧, 李霞, 等. 康妇炎胶囊联合宫腹腔镜再通术治疗输卵管结扎后复通疗效及妊娠结局[J]. 昆明医科大学学报, 2022, 43(2): 112-117.
[72] 段雪娇. 腹宫腔镜再通术结合康妇炎胶囊治疗重度输卵管通而不畅不孕效果观察[J]. 实用中医药杂志, 2020, 36(9): 1183-1184.